
Olmetense AH 40mg/5mg/12.5mg Tablet
Marketer
Werke Healthcare
Salt Composition
Olmesartan Medoxomil (40mg) + Amlodipine (5mg) + Hydrochlorothiazide (12.5mg)
Overview Olmetense AH 40mg/5mg/12.5mg Tablet
Combipress HT 40mg/5mg/12.5mg tablets combine medications to manage hypertension when monotherapy proves insufficient. This regimen lowers elevated blood pressure, mitigating the risk of future strokes and heart attacks. Administer Combipress HT 40mg/5mg/12.5mg with or without food, at the same time daily, as prescribed; dosage is individualized. Continuous use, as directed by your physician, is crucial. The diuretic component increases urination; therefore, avoid late-day administration (within four hours of bedtime). Consistent use optimizes therapeutic effects, even during symptom-free periods; untreated hypertension is frequently asymptomatic. Cessation may increase stroke or heart attack risk. Common side effects include edema (ankle swelling), cephalgia (headache), vertigo (dizziness), fatigue, and altered taste perception. Report persistent, worsening, or bothersome side effects to your doctor. Maintain adequate hydration to minimize potential muscle weakness, xerostomia (dry mouth), and polydipsia (excessive thirst). Prior to commencing treatment, inform your doctor of any renal or hepatic (liver) impairment, pregnancy, or breastfeeding. Comprehensive disclosure of all concurrent medications, especially cardiovascular agents, is essential. Regular monitoring of blood pressure, renal function, electrolyte levels, and glycemia (blood sugar) ensures optimal treatment efficacy.
Uses of Olmetense AH 40mg/5mg/12.5mg Tablet
Elevated arterial blood pressure
Major Benefits of Olmetense AH 40mg/5mg/12.5mg Tablet:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the 40mg/5mg/12.5mg Olmetense AH tablet whole; avoid chewing, crushing, or fracturing it. While this medication can be taken with or without food, consistent timing is recommended for optimal results.
Common Side effects of Olmetense AH 40mg/5mg/12.5mg Tablet:
- Headache
- Dizziness
- Nausea
- Upper respiratory tract infection
- Fatigue
- Urinary tract infection
- Diarrhea
- Joint swelling
- Peripheral edema
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Muscle spasm
- Hypotension (low blood pressure)
- Increased creatinine level in blood
- Increased blood urea
- Increased uric acid level in blood
How to use Olmetense AH 40mg/5mg/12.5mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Olmetense AH 40mg/5mg/12.5mg Tablet can be administered with or without food, though consistent timing is recommended.
How Olmetense AH 40mg/5mg/12.5mg Tablet works:
Olmetense AH 40mg/5mg/12.5mg tablets contain olmesartan medoxomil, amlodipine, and hydrochlorothiazide, working synergistically to manage hypertension. Olmesartan medoxomil, an angiotensin II receptor antagonist, and amlodipine, a calcium channel blocker, both promote vasodilation, reducing blood pressure. Hydrochlorothiazide, a thiazide diuretic, lowers blood pressure by increasing urinary excretion of sodium and water, and contributes to vasodilation over time.
SAFETY ADVICE
AlcoholUNSAFE
Combining Olmetense AH 40mg/5mg/12.5mg tablets with alcohol is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Using Olmetense AH 40mg/5mg/12.5mg tablets during pregnancy poses a confirmed risk to the fetus. Therefore, its use is discouraged. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known dangers. Always seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Olmetense AH 40mg/5mg/12.5mg tablets while breastfeeding is likely inadvisable. Available evidence from human studies indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Driving ability may be impaired by Olmetense AH 40mg/5mg/12.5mg Tablets, due to potential side effects. These side effects can include dizziness, headaches, nausea, or fatigue, potentially impacting concentration and safe driving.
KidneyCAUTION
Patients with severe kidney impairment should exercise caution when using Olmetense AH 40mg/5mg/12.5mg tablets, as dose modification may be necessary. A physician's consultation is advised. Olmetense AH 40mg/5mg/12.5mg tablets are generally not recommended for individuals with severe kidney disease.
LiverCAUTION
Patients with liver impairment should exercise caution when using Olmetense AH 40mg/5mg/12.5mg tablets. Dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Olmetense AH 40mg/5mg/12.5mg Tablet :
Should you forget to take your Olmetense AH 40mg/5mg/12.5mg Tablet, administer it immediately. However, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Olmetense AH 40mg/5mg/12.5mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Heart |
